Mandrola's Top 10 Cardiology Stories of 2021

Obesity drugs had a good year, the SGLT2 inhibitors stalled, and Entresto looks less impressive -- these are some of the takes from John Mandrola, MD, in his annual review of cardiology research.

Related Keywords

Sweden ,United States ,Kentucky ,John Mandrola ,Jay Brophy ,John Hampton ,Gabriel Steg ,Mcgill University ,Bad News ,Glucose Cotransporter ,Less Impressive Year ,Left Atrial Appendage Closure Shines ,Left Atrial Appendage Closure ,Not So Much ,Receptor Neprilysin Inhibitor Also ,Coronary Artery Disease Looks Highly Stable ,Bayes Makes ,Randomized Trial ,Therapeutic Fashion ,New England Journal ,Heart Failure ,Acute Coronary Syndrome Acs ,Cute Coronary Syndrome ,Cs ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,Coronary Atherosclerosis ,Lipids ,Ipid Management ,Angina ,Angina Pectoris ,Obesity ,Bese ,Asystole ,Atrial Fibrillation ,F Atrial Fibrillation ,Cardiac Arrest ,Myocardial Infarction ,Unstable Angina ,Becg ,Electroc ,